Skip to main content
Clinical Trials/CTIS2023-508316-27-00
CTIS2023-508316-27-00
Active, not recruiting
Phase 1

Preoperative Indocyanine Green administration increases intraoperative detection of Liver Tumors in Imaging-guided surgery. A phase IV clinical trial. - LIVERGREE

Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron0 sites173 target enrollmentNovember 28, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients with liver tumors that will undergo minimally invasive liver surgery
Sponsor
Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron
Enrollment
173
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 28, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron

Eligibility Criteria

Inclusion Criteria

  • Patients with liver tumors with an indication for minimally invasive surgery, evaluated by the hospital’s multidisciplinary liver tumor board (MDTB)., Contrast enhanced MRI within 6 weeks prior to liver surgery, \=18 years old, Absence of exclusion criteria and able to provide consent for data collection and analysis

Exclusion Criteria

  • Emergency surgery, Patients in which ICG is contraindicated (one condition will be enough for excluding the patient): 1\.previous history of iodine hypersensitivity; 2\. patients with renal failure (GFR \<60 mL/min/1\.73 m2\); 3 uremic syndrome; 4\. clinical hyperthyroidism; 5\. autonomic thyroid adenomas; or 6\. focal and diffuse autonomic abnormalities of the thyroid gland., Previous liver surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials